🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200

RecruitingNAAges 50 Years - anyAllNext Biomedical Co., Ltd.
NCT06930677 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Study in patients with knee osteoarthritis treated by embolization using NBGM200

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Osteoarthritis proven by MR-imaging Exclusion Criteria: * Current local infection * Life expectancy less than 6 months
💊

What it tests

  • embolization therapy
📍

Where

3 sites
University Hospital Ghent
Ghent, Belgium
Uz Leuven
Leuven, Belgium
Elisabeth-Tweesteden Hospital
Tilburg, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy